Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Twist Bioscience Corp
Report date April 01, 2021 · Filed April 07, 2021
Section 16 reporting ended · disclosed 2021-04-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 66,736 |
Reported balance
After 2021-04-01 transaction · row 1
1 source rowRow 1 · 2021-04-01 · Tax withholding · Disposed 190 · Balance 66,736 F1: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 24, 2020 Filed Dec 29, 2020 22:53 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 620 | $23.33 | $14,464.60 |
DisclosureSEC source: 0001214659-20-010742 · marketforms-50726.xml · nonDerivative · entry 1 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,407 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 21, 2020 Filed Dec 23, 2020 21:32 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,625 | $0.00 Strike: $10.70 | $0.00 |
DisclosureSEC source: 0001214659-20-010649 · marketforms-50700.xml · derivative · entry 4 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,691 Underlying: Common Stock · 5,625 shares Expires 2028-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is immediately exercisable. 25% of the shares subject to the option vest on January 1, 2019, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| December 21, 2020 Filed Dec 23, 2020 21:32 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,826 | $0.00 Strike: $8.82 | $0.00 |
DisclosureSEC source: 0001214659-20-010649 · marketforms-50700.xml · derivative · entry 3 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,769 Underlying: Common Stock · 6,826 shares Expires 2027-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| December 21, 2020 Filed Dec 23, 2020 21:32 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 5,625 | $10.70 | $60,187.50 |
DisclosureSEC source: 0001214659-20-010649 · marketforms-50700.xml · nonDerivative · entry 2 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,787 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 21, 2020 Filed Dec 23, 2020 21:32 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 6,826 | $8.82 | $60,205.32 |
DisclosureSEC source: 0001214659-20-010649 · marketforms-50700.xml · nonDerivative · entry 1 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,162 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,878 | $0.00 Strike: $5.95 | $0.00 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · derivative · entry 34 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,878 shares Expires 2026-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F30 · derivative.exercise_date: The option is immediately exercisable. 25% of the shares subject to the option vested on August 8, 2017 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 8,065 | $0.00 Strike: $23.33 | $0.00 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · derivative · entry 33 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,715 Underlying: Common Stock · 8,065 shares Expires 2029-10-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F29 · derivative.exercise_date: 25% of the shares subject to the option vested on October 24, 2020, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 29,158 | $0.00 Strike: $26.66 | $0.00 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · derivative · entry 32 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,842 Underlying: Common Stock · 29,158 shares Expires 2028-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F28 · derivative.exercise_date: 20% of the shares subject to the option vested on October 31, 2019 and 1/60th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 17,772 | $0.00 Strike: $10.70 | $0.00 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · derivative · entry 31 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,316 Underlying: Common Stock · 17,772 shares Expires 2028-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F27 · derivative.exercise_date: The option is immediately exercisable. 25% of the shares subject to the option vest on January 1, 2019, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,971 | $0.00 Strike: $8.82 | $0.00 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · derivative · entry 30 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,595 Underlying: Common Stock · 2,971 shares Expires 2027-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F26 · derivative.exercise_date: The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 90 | $139.22 | $12,529.63 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · nonDerivative · entry 29 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,336 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. F25 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $139.03 to $139.53 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 201 | $138.01 | $27,740.11 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · nonDerivative · entry 28 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,426 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. F24 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $137.71 to $138.63 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 187 | $136.96 | $25,611.26 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · nonDerivative · entry 27 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,627 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. F23 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $136.64 to $137.34 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 60 | $135.81 | $8,148.80 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · nonDerivative · entry 26 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,814 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. F22 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $135.60 to $135.92 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 211 | $134.18 | $28,312.32 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · nonDerivative · entry 25 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,874 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. F21 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $133.99 to $134.64 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 183 | $131.76 | $24,112.24 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · nonDerivative · entry 24 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,085 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. F20 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $131.69 to $131.83 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 95 | $130.92 | $12,437.14 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · nonDerivative · entry 23 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,268 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. F19 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $130.52 to $131.26 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 298 | $129.13 | $38,481.43 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · nonDerivative · entry 22 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,363 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. F18 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $128.85 to $129.51 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 109 | $127.50 | $13,897.55 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · nonDerivative · entry 21 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,661 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. F17 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $127.10 to $128.07 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 197 | $126.64 | $24,947.67 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · nonDerivative · entry 20 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,770 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. F16 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $126.01 to $126.95 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 780 | $139.43 | $108,757.51 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · nonDerivative · entry 19 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,967 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. F15 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $139.31 to $139.53 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 5,146 | $138.98 | $715,181.82 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · nonDerivative · entry 18 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,747 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. F14 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $138.31 to $139.27 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 7,400 | $137.91 | $1,020,514.76 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · nonDerivative · entry 17 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,893 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. F13 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $137.31 to $138.30 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 8,610 | $136.74 | $1,177,324.51 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · nonDerivative · entry 16 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,293 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. F12 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $136.30 to $137.27 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,613 | $135.78 | $354,794.19 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · nonDerivative · entry 15 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,903 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. F11 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $135.30 to $136.26 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,355 | $134.71 | $182,526.36 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · nonDerivative · entry 14 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,516 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. F10 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $134.26 to $135.15 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 4,108 | $133.72 | $549,330.39 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · nonDerivative · entry 13 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,871 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. F9 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $133.18 to $134.16 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,569 | $132.55 | $473,055.60 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · nonDerivative · entry 12 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,979 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. F8 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $132.07 to $133.05 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 8,450 | $131.55 | $1,111,572.15 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · nonDerivative · entry 11 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,548 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. F7 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $131.03 to $132.01 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,431 | $130.40 | $447,403.77 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · nonDerivative · entry 10 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,998 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. F6 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $129.99 to $130.86 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 6,700 | $129.38 | $866,839.97 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · nonDerivative · entry 9 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,429 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $128.95 to $129.93 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 6,803 | $128.52 | $874,301.83 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · nonDerivative · entry 8 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,129 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $127.95 to $128.94 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 5,774 | $127.06 | $733,646.75 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · nonDerivative · entry 7 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,932 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $126.88 to $127.86 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 4,105 | $126.37 | $518,737.36 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · nonDerivative · entry 6 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,706 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $125.88 to $126.85 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 10,878 | $5.95 | $64,724.10 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · nonDerivative · entry 5 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,811 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 8,065 | $23.33 | $188,156.45 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · nonDerivative · entry 4 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,933 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 29,158 | $26.66 | $777,352.28 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · nonDerivative · entry 3 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,868 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 17,772 | $10.70 | $190,160.40 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · nonDerivative · entry 2 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,710 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 2,971 | $8.82 | $26,204.22 |
DisclosureSEC source: 0001214659-20-010514 · marketforms-50656.xml · nonDerivative · entry 1 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,938 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 22:54 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 744 | $115.56 | $85,976.64 |
DisclosureSEC source: 0001214659-20-009874 · marketforms-50159.xml · nonDerivative · entry 1 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,967 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| October 24, 2020 Filed Oct 27, 2020 20:50 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 862 | $85.97 | $74,106.14 |
DisclosureSEC source: 0001214659-20-008877 · marketforms-49867.xml · nonDerivative · entry 1 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,711 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| September 01, 2020 Filed Sep 4, 2020 00:38 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 6,140 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-007684 · marketforms-49590.xml · nonDerivative · entry 1 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,573 F1 · shares: Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of October 1, 2020, for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 21:42 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 744 | $67.28 | $50,056.32 |
DisclosureSEC source: 0001214659-20-007448 · marketforms-49492.xml · nonDerivative · entry 1 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,433 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). F2 · balance_after: Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| August 17, 2020 Filed Aug 18, 2020 22:52 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 20,994 | $0.00 Strike: $5.95 | $0.00 |
DisclosureSEC source: 0001214659-20-007348 · marketforms-49480.xml · derivative · entry 5 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,878 Underlying: Common Stock · 20,994 shares Expires 2026-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is immediately exercisable. 25% of the shares subject to the option vested on August 8, 2017 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| August 17, 2020 Filed Aug 18, 2020 22:52 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 7,500 | $69.00 | $517,500.00 |
DisclosureSEC source: 0001214659-20-007348 · marketforms-49480.xml · nonDerivative · entry 4 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,718 Read SEC document |
| August 17, 2020 Filed Aug 18, 2020 22:52 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 7,500 | $68.00 | $510,000.00 |
DisclosureSEC source: 0001214659-20-007348 · marketforms-49480.xml · nonDerivative · entry 3 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,218 Read SEC document |
| August 17, 2020 Filed Aug 18, 2020 22:52 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 5,994 | $67.00 | $401,598.00 |
DisclosureSEC source: 0001214659-20-007348 · marketforms-49480.xml · nonDerivative · entry 2 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,718 Read SEC document |
| August 17, 2020 Filed Aug 18, 2020 22:52 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 20,994 | $5.95 | $124,914.30 |
DisclosureSEC source: 0001214659-20-007348 · marketforms-49480.xml · nonDerivative · entry 1 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,712 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2020 Filed Aug 17, 2020 20:24 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 9,006 | $0.00 Strike: $5.95 | $0.00 |
DisclosureSEC source: 0001214659-20-007257 · marketforms-49453.xml · derivative · entry 8 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,872 Underlying: Common Stock · 9,006 shares Expires 2026-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is immediately exercisable. 25% of the shares subject to the option vested on August 8, 2017 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| August 14, 2020 Filed Aug 17, 2020 20:24 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,506 | $67.00 | $100,902.00 |
DisclosureSEC source: 0001214659-20-007257 · marketforms-49453.xml · nonDerivative · entry 6 Daniels Mark · CIK 0001753840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,718 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.